The Legal Intelligencer | Commentary
By Marissa Schwartz, Mary Anne Batiz and Nicole Scott | May 13, 2024
Our clients remind us of what justice and equality looks like for real individuals, outside the theoretical ideals described in laws and textbooks.
The Legal Intelligencer | Commentary
By David G. Mandelbaum | May 13, 2024
Just as a lawyer must have a basic understanding of many things that may affect a client's business or activities, the lawyer also has to have a basic understanding of how a changing climate will have changing effects on clients
The Legal Intelligencer | Commentary
By Dallis Terc | May 10, 2024
Employers need to consider the processing times and plan accordingly until processing times improve.
The Legal Intelligencer | Commentary
By Jules Epstein | May 10, 2024
Lay witnesses may not cross a line and give testimony that is "based on scientific, technical, or other specialized knowledge within the scope of Rule 702." That's for experts, and with expert testimony comes discovery obligations such as reports and CVs.
The Legal Intelligencer | Commentary
By Patrick J. Smith and Deanna J. Lucci | May 9, 2024
Pennsylvania seeks to become the 25th state to legalize recreational cannabis for adult use and establish standards for, among other things, the marketing of cannabis facilities and products.
The Legal Intelligencer | Commentary
By Timothy J. Horstmann and Kenneth Stark | May 9, 2024
The grants are funded through the U.S. Treasury under the American Rescue Plan Act of 2021 (ARPA), which authorized the use of funds for broadband infrastructure projects targeted at unserved or underserved households and businesses. Combined with private matching funds, the awards will result in over $400 million of broadband projects throughout Pennsylvania.
The Legal Intelligencer | Commentary
By Edward Waddington and Jesse LaGrossa | May 9, 2024
The considerations for determining the financial loss in a federal criminal matter are analogous to those a practitioner may employ in other issues requiring measuring a financial loss (i.e., damages in civil litigation).
The Legal Intelligencer | Commentary
By Benjamin P. Sheppard | May 8, 2024
The judicial landscape, at both the state and federal levels, is tasked with determining the existence of a private cause of action under each state's medical cannabis statute. This determination hinges on whether the statute delegates enforcement responsibilities to a governmental entity, or if it lacks an independent mechanism for addressing employer violations.
The Legal Intelligencer | Commentary
By Rich Lee | May 8, 2024
For this month's feature, I had the pleasure of speaking with Robyn Weinstein, who has dedicated her career to the advancement and craft of conflict resolution.
The Legal Intelligencer | Commentary
By Tariq Naeem | May 7, 2024
Momentum has been gathering behind efforts to reclassify marijuana under the Controlled Substances Act (CSA). Regardless of how marijuana is rescheduled under federal law, the Food and Drug Administration (FDA) could consider medical marijuana products to be unapproved "new drugs" subject to regulation under the Food, Drug, and Cosmetic Act (FDCA).
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law.com celebrates the California law firms and legal departments driving the state's dynamic legal landscape.
The Texas Lawyer honors attorneys and judges who have made a remarkable difference in the legal profession in Texas.
Javerbaum Wurgaft, a large civil litigation firm with nine (9) offices, seeks: Plaintiff Personal Injury Attorney for Northern New Jersey of...
Mid sized NYC Personal Injury Defense Firm seeking to immediately hire several attorneys to join our firm. Preferred candidates are those w...
Mid-size Parsippany based law firm with a statewide practice is searching for a full-time motivated associate litigation attorney with 3-5 y...